Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.

Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD; INRG Task Force.

J Clin Oncol. 2009 Jan 10;27(2):298-303. doi: 10.1200/JCO.2008.16.6876. Epub 2008 Dec 1.

2.

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK; INRG Task Force.

J Clin Oncol. 2009 Jan 10;27(2):289-97. doi: 10.1200/JCO.2008.16.6785. Epub 2008 Dec 1.

3.

Imaging neuroblastoma: what the radiologist needs to know.

McCarville MB.

Cancer Imaging. 2011 Oct 3;11 Spec No A:S44-7. doi: 10.1102/1470-7330.2011.9008. Review.

4.

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.

Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, Giammarile F, Schmidt M, Shulkin BL, Matthay KK, Lewington VJ, Sarnacki S, Hero B, Kaneko M, London WB, Pearson AD, Cohn SL, Monclair T; International Neuroblastoma Risk Group Project.

Radiology. 2011 Oct;261(1):243-57. doi: 10.1148/radiol.11101352. Epub 2011 May 17.

PMID:
21586679
5.

Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.

Irtan S, Brisse HJ, Minard-Colin V, Schleiermacher G, Galmiche-Rolland L, Le Cossec C, Elie C, Canale S, Michon J, Valteau-Couanet D, Sarnacki S.

Pediatr Blood Cancer. 2015 Sep;62(9):1543-9. doi: 10.1002/pbc.25511. Epub 2015 Mar 27.

PMID:
25820608
6.

Bilateral adrenal neuroblastoma in the infant: Is it an image-defined risk factor?

Marino S, La Spina M, Scuderi MG, Di Benedetto V, Magro G, Belfiore G, Coronella M, D'Amico S, Lo Nigro L, Russo G, Di Cataldo A.

Pediatr Hematol Oncol. 2016 May;33(4):259-63. doi: 10.3109/08880018.2016.1160169.

PMID:
27285992
7.

Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.

Monclair T, Mosseri V, Cecchetto G, De Bernardi B, Michon J, Holmes K.

Pediatr Blood Cancer. 2015 Sep;62(9):1536-42. doi: 10.1002/pbc.25460. Epub 2015 Feb 8.

PMID:
25663103
8.

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

Matthay KK, Shulkin B, Ladenstein R, Michon J, Giammarile F, Lewington V, Pearson AD, Cohn SL.

Br J Cancer. 2010 Apr 27;102(9):1319-26. doi: 10.1038/sj.bjc.6605621. Review.

9.

Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.

Taggart DR, London WB, Schmidt ML, DuBois SG, Monclair TF, Nakagawara A, De Bernardi B, Ambros PF, Pearson AD, Cohn SL, Matthay KK.

J Clin Oncol. 2011 Nov 20;29(33):4358-64. doi: 10.1200/JCO.2011.35.9570. Epub 2011 Oct 3.

10.

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, Schleiermacher G, Speleman F, Spitz R, London WB, Cohn SL, Pearson AD, Maris JM.

Br J Cancer. 2009 May 5;100(9):1471-82. doi: 10.1038/sj.bjc.6605014.

11.

[New international staging system and classification of risk groups in neuroblastoma].

Balwierz W, Wieczorek A.

Przegl Lek. 2010;67(6):345-9. Polish.

PMID:
21344759
12.

Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?

Iehara T, Hiyama E, Tajiri T, Yoneda A, Hamazaki M, Fukuzawa M, Hosoi H, Sugimoto T, Sawada T.

Eur J Cancer. 2012 Jul;48(11):1707-12. doi: 10.1016/j.ejca.2012.01.010. Epub 2012 Feb 1.

PMID:
22305511
13.

Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in Western Japan.

Fumino S, Kimura K, Iehara T, Nishimura M, Nakamura S, Souzaki R, Nishie A, Taguchi T, Hosoi H, Tajiri T.

J Pediatr Surg. 2015 Dec;50(12):2102-6. doi: 10.1016/j.jpedsurg.2015.08.039. Epub 2015 Aug 28.

PMID:
26388125
14.

Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems.

Haase GM, Atkinson JB, Stram DO, Lukens JN, Matthay KK.

J Pediatr Surg. 1995 Feb;30(2):289-94; discussion 295.

PMID:
7738753
15.

Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.

Bagatell R, Beck-Popovic M, London WB, Zhang Y, Pearson AD, Matthay KK, Monclair T, Ambros PF, Cohn SL; International Neuroblastoma Risk Group.

J Clin Oncol. 2009 Jan 20;27(3):365-70. doi: 10.1200/JCO.2008.17.9184. Epub 2008 Dec 1.

16.

Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma.

Pohl A, Erichsen M, Stehr M, Hubertus J, Bergmann F, Kammer B, von Schweinitz D.

Klin Padiatr. 2016 Apr;228(3):118-23. doi: 10.1055/s-0041-111175. Epub 2016 Feb 29.

PMID:
26930233
17.

Can neoadjuvant chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors at the time of diagnosis?

Yoneda A, Nishikawa M, Uehara S, Oue T, Usui N, Inoue M, Fukuzawa M, Okuyama H.

Pediatr Surg Int. 2016 Mar;32(3):209-14. doi: 10.1007/s00383-016-3858-5. Epub 2016 Jan 13.

PMID:
26763000
18.

The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.

Russell HV, Golding LA, Suell MN, Nuchtern JG, Strother DR.

Pediatr Blood Cancer. 2005 Dec;45(7):916-9.

PMID:
16078212
19.

Experience with International Neuroblastoma Staging System and Pathology Classification.

Ikeda H, Iehara T, Tsuchida Y, Kaneko M, Hata J, Naito H, Iwafuchi M, Ohnuma N, Mugishima H, Toyoda Y, Hamazaki M, Mimaya J, Kondo S, Kawa K, Okada A, Hiyama E, Suita S, Takamatsu H.

Br J Cancer. 2002 Apr 8;86(7):1110-6.

20.

Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial.

Simon T, Hero B, Benz-Bohm G, von Schweinitz D, Berthold F.

Pediatr Blood Cancer. 2008 May;50(5):965-9.

PMID:
17914735

Supplemental Content

Support Center